Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are Cushing's disease patients curable?

Xavier Bertagna1

  • 1Service des maladies endocriniennes et métaboliques, centre de référence des maladies rares de la surrénale, hôpital Cochin, faculté de médecine Paris-Descartes, université Paris 5, 24, rue du Faubourg-St-Jacques, 75014 Paris, France.

Annales D'Endocrinologie
|April 14, 2018
PubMed
Summary

Treating Cushing's disease is difficult, as pituitary surgery has limitations. Alternative therapies are often necessary due to treatment failures and recurrences, highlighting the need for ongoing research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic characterization of aggressiveness in pituitary neuroendocrine tumors (PitNETs).

Neuro-oncology·2026
Same author

Progression of potentially aggressive pituitary neuroendocrine tumors after radiotherapy: risk factors, management, and outcomes.

European journal of endocrinology·2025
Same author

Prevalence of treated hyper- and hypo-thyroidism and sociodemographic and geographic disparities in France in 2020.

European thyroid journal·2025
Same author

From Nelson's Syndrome to Corticotroph Tumor Progression Speed: An Update.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2024
Same author

Testicular impairment in Primary Adrenal Insufficiency caused by Nicotinamide Nucleotide Transhydrogenase (NNT) deficiency - a case report: implication of oxidative stress and importance of fertility preservation.

Basic and clinical andrology·2023
Same author

Comment on "Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology".

European journal of drug metabolism and pharmacokinetics·2023

Area of Science:

  • Endocrinology
  • Neurosurgery
  • Oncology

Background:

  • Cushing's disease, a rare endocrine disorder, presents significant treatment challenges.
  • While pituitary surgery offers a potential cure, high rates of immediate failure and late recurrence necessitate alternative therapeutic strategies.
  • Current alternative treatments for Cushing's disease are numerous but possess notable drawbacks, often serving as default options.

Purpose of the Study:

  • To review the current therapeutic landscape for Cushing's disease.
  • To highlight the limitations of existing treatment modalities.
  • To emphasize the ongoing need for optimized therapeutic approaches and research into pituitary adenoma management.

Main Methods:

  • Literature review of existing studies on Cushing's disease treatment.
Keywords:
Chirurgie surrénalienneCushing's diseaseFonction hypophyso-surrénalienneMaladie de CushingPituitary adrenal axisPituitary surgery

Related Experiment Videos

  • Analysis of surgical outcomes, including cure rates, failures, and recurrences.
  • Evaluation of the efficacy and drawbacks of medical and radiation therapies.

    • Main Results:

    • Pituitary surgery can cure Cushing's disease and normalize the pituitary adrenal axis.
    • Significant rates of immediate surgical failure and late recurrence persist.
    • Alternative therapies, while available, are often considered default options with inherent limitations.

    Conclusions:

    • Effective management of Cushing's disease remains a complex clinical challenge.
    • The persistent issues with primary treatment necessitate a critical evaluation of all therapeutic options.
    • Pituitary adenoma management requires continued focus and innovation from healthcare professionals.